Title:
IDENTIFICATION AND USES OF PEPTIDE SEQUENCES OF SARS-COV-2 T CELL AND B CELL EPITOPES
Document Type and Number:
WIPO Patent Application WO/2022/148455
Kind Code:
A1
Abstract:
The present disclosure identifies a set of T cell and B cell epitopes derived from Severe Acute Respiratory Syndrome Coronavirus 1 (SARS-CoV-1) and their use in designing vaccines against SARS-CoV-2. A method for eliciting an immune response for prophylactic or therapeutic application using the T cell and/or B cell epitopes is described. Further disclosed are SARS-CoV-2-specific polypeptides, nucleic acids, host cells, and corresponding compositions for eliciting or measuring an immune response to SARS-CoV-2 and/or other coronaviruses.
Inventors:
MCKAY MATTHEW ROBERT (CN)
QUADEER AHMED ABDUL (CN)
AHMED SYED FARAZ (CN)
SOHAIL MUHAMMAD SAQIB (CN)
QUADEER AHMED ABDUL (CN)
AHMED SYED FARAZ (CN)
SOHAIL MUHAMMAD SAQIB (CN)
Application Number:
PCT/CN2022/070948
Publication Date:
July 14, 2022
Filing Date:
January 10, 2022
Export Citation:
Assignee:
UNIV HONG KONG SCIENCE & TECH (CN)
International Classes:
C07K14/005; A61K38/16; A61P31/14; C12N15/13; C12N15/63; G01N33/53
Foreign References:
| CN111228483A | 2020-06-05 | |||
| CN111440229A | 2020-07-24 | |||
| CN112194711A | 2021-01-08 | |||
| CN111358943A | 2020-07-03 | |||
| CN111939250A | 2020-11-17 |
Attorney, Agent or Firm:
INSIGHT INTELLECTUAL PROPERTY LIMITED (CN)
Download PDF: